Raymond Debbane
Director · LEXICON PHARMACEUTICALS, INC.
- 2025
- Jun 4, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Raymond Debbane files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Invus Global Management, LLC - $2.00M in LXRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Raymond Debbane?
Raymond Debbane is a corporate insider, tracked as Director of LEXICON PHARMACEUTICALS, INC. (LXRX). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Raymond Debbane last file a Form 4?
The most recent primary Form 4 on record is dated 4 June 2026, one of 8 filings going back to 2025.
Has Raymond Debbane been buying or selling stock?
Recorded transactions: 7 open-market purchases ($723K) and 0 open-market sales across all tracked filings.
